thiazoles has been researched along with ds-5272 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aonuma, M; Fukutake, S; Kawato, H; Kitagawa, M; Miyazaki, M; Naito, H; Okayama, T; Seki, T; Soga, T; Sugimoto, Y; Uoto, K; Yoshida, K | 1 |
| Anders, HJ; Fujikura, T; Iwakura, T; Tsuji, T; Yasuda, H | 1 |
| Asada, S; Fukuyama, T; Goyama, S; Hayashi, Y; Kitamura, T; Liu, X; Matsuda, K; Matsumoto, A; Mizukawa, B; O'Brien, E; Sashida, G; Shibata, T; Takizawa, H; Tamura, M; Tanaka, Y; Wunderlich, M; Yamasaki, S; Yamazaki, S | 1 |
| Ayabe, T; Fujii, T; Hiraike, H; Honjo, H; Kawata, Y; Kojima, M; Makii, C; Matsumoto, Y; Miyagawa, Y; Nagasaka, K; Oda, K; Oki, S; Osuga, Y; Sone, K; Taguchi, A; Takeuchi, M; Tanikawa, M; Wada-Hiraike, O | 1 |
4 other study(ies) available for thiazoles and ds-5272
| Article | Year |
|---|---|
Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Fluorine; Gene Expression; Humans; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Binding; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Sarcoma; Thiazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
MDM2 inhibitor ameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition.
Topics: Acute Kidney Injury; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molecules; Cisplatin; Disease Models, Animal; HEK293 Cells; Humans; Imidazoles; Kidney Tubules; Male; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Treatment Outcome | 2019 |
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia.
Topics: Animals; B7-H1 Antigen; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Immunotherapy; Inflammation; Killer Cells, Natural; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins c-mdm2; Thiazoles; Tumor Suppressor Protein p53 | 2019 |
Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.
Topics: Adenocarcinoma, Clear Cell; Animals; Apoptosis; Carcinoma, Renal Cell; Cell Cycle; Cell Proliferation; Disease Models, Animal; Everolimus; Female; Heterografts; Humans; Imidazoles; Kidney; Mice; Ovarian Neoplasms; Peritonitis; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-mdm2; Thiazoles; TOR Serine-Threonine Kinases | 2020 |